Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


25.09.2017

2 AIDS
1 Am J Gastroenterol
1 Dig Dis Sci
2 Eur J Gastroenterol Hepatol
1 Gut
4 Hepatology
1 J Hepatol
1 J Infect Dis
1 J Med Virol
1 J Virol
1 JAMA
2 Lancet Glob Health
1 Lancet Oncol
1 MMWR Morb Mortal Wkly Rep
4 PLoS One
1 PLoS Pathog
2 Transplant Proc
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. KUNIHOLM MH, Liang H, Anastos K, Gustafson D, et al
    Association of a 3' Untranslated Region Polymorphism in PCSK9 with HIV Viral Load and CD4+ Levels in HIV/Hepatitis C Virus Co-Infected Women.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001648.
    PubMed     Text format     Abstract available

  2. THORNTON AC, Jose S, Bhagani S, Chadwick D, et al
    Hepatitis B, hepatitis C and mortality among HIV-positive individuals.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001646.
    PubMed     Text format     Abstract available


    Am J Gastroenterol

  3. LENS S, Fernandez I, Rodriguez-Tajes S, Hontangas V, et al
    Interferon-Free Therapy in Elderly Patients With Advanced Liver Disease.
    Am J Gastroenterol. 2017;112:1400-1409.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  4. HOSSAIN N, Puchakayala B, Kanwar P, Verma S, et al
    Risk Factor Analysis Between Newly Screened and Established Hepatitis C in GI and Hepatology Clinics.
    Dig Dis Sci. 2017 Sep 14. doi: 10.1007/s10620-017-4754.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  5. TRIANTOS CK, Tsintoni A, Karaivazoglou K, Grigoropoulou X, et al
    Male hepatitis C patients' sexual functioning and its determinants.
    Eur J Gastroenterol Hepatol. 2017 Sep 13. doi: 10.1097/MEG.0000000000000971.
    PubMed     Text format     Abstract available

  6. WRIGHT N, Reimer J, Somaini L, Roncero C, et al
    Are we ready to treat hepatitis C virus in individuals with opioid use disorder: assessment of readiness in European countries on the basis of an expert-generated model.
    Eur J Gastroenterol Hepatol. 2017 Sep 13. doi: 10.1097/MEG.0000000000000962.
    PubMed     Text format     Abstract available


    Gut

  7. WU T, Li J, Shao L, Xin J, et al
    Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure.
    Gut. 2017 Sep 19. pii: gutjnl-2017-314641. doi: 10.1136/gutjnl-2017-314641.
    PubMed     Text format     Abstract available


    Hepatology

  8. WYLES D, Poordad F, Wang S, Alric L, et al
    Glecaprevir/Pibrentasvir for HCV Genotype 3 Patients with Cirrhosis and/or Prior Treatment Experience: A Partially Randomized Phase III Clinical Trial.
    Hepatology. 2017 Sep 19. doi: 10.1002/hep.29541.
    PubMed     Text format     Abstract available

  9. VIONNET J, Pascual M, Testoni B, Combet C, et al
    Late hepatitis B reactivation following DAA-based treatment of recurrent hepatitis C in an anti-HBc-positive liver transplant recipient.
    Hepatology. 2017 Sep 16. doi: 10.1002/hep.29528.
    PubMed     Text format    

  10. LEE MH, Huang YH, Chen HY, Khor CS, et al
    Human Leukocyte Antigen Variants and Risk of Hepatocellular Carcinoma Modified by HCV Genotypes: A Genome-wide Association Study.
    Hepatology. 2017 Sep 16. doi: 10.1002/hep.29531.
    PubMed     Text format     Abstract available

  11. KIM JH, Sinn DH, Kang W, Gwak GY, et al
    Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28916.
    PubMed     Text format     Abstract available


    J Hepatol

  12. PRENNER S, Kulik L
    Reply to "Treatment failure after interferon-free treatment of hepatitis C as a clue of a yet undetected hepatocellular carcinoma".
    J Hepatol. 2017 Sep 13. pii: S0168-8278(17)32283.
    PubMed     Text format    


    J Infect Dis

  13. TAI CS, Wu JF, Chen HL, Ni YH, et al
    The Impact of Hepatitis B Vaccine Failure on Long-term Natural Course of Chronic Hepatitis B Virus Infection in Hepatitis B e Antigen-Seropositive Children.
    J Infect Dis. 2017;216:662-669.
    PubMed     Text format     Abstract available


    J Med Virol

  14. ALVARADO-ESQUIVEL C, Sanchez-Anguiano LF, Hernandez-Tinoco J, Alvarado-Felix AO, et al
    Seroepidemiology of hepatitis E virus infection in pigs in Durango State, Mexico.
    J Med Virol. 2017 Sep 15. doi: 10.1002/jmv.24951.
    PubMed     Text format     Abstract available


    J Virol

  15. FAUTEUX-DANIEL S, Larouche A, Calderon V, Boulais J, et al
    Vertical transmission of hepatitis C virus: variable transmission bottleneck and evidence of mid-gestation in utero infection.
    J Virol. 2017 Sep 20. pii: JVI.01372-17. doi: 10.1128/JVI.01372.
    PubMed     Text format     Abstract available


    JAMA

  16. COHEN JM, Femia AN, Ho RS
    A Woman With Purple Macules on the Legs.
    JAMA. 2017;318:569-570.
    PubMed     Text format    


    Lancet Glob Health

  17. MANNS MP
    Hepatitis D virus in Africa: several unmet needs.
    Lancet Glob Health. 2017;5:e953-e954.
    PubMed     Text format    

  18. STOCKDALE AJ, Chaponda M, Beloukas A, Phillips RO, et al
    Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis.
    Lancet Glob Health. 2017;5:e992-e1003.
    PubMed     Text format     Abstract available


    Lancet Oncol

  19. BRAWLEY OW
    The role of government and regulation in cancer prevention.
    Lancet Oncol. 2017;18:e483-e493.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  20. LATASH J, Dorsinville M, Del Rosso P, Antwi M, et al
    Notes from the Field: Increase in Reported Hepatitis A Infections Among Men Who Have Sex with Men - New York City, January-August 2017.
    MMWR Morb Mortal Wkly Rep. 2017;66:999-1000.
    PubMed     Text format     Abstract available


    PLoS One

  21. TUDESQ JJ, Dunyach-Remy C, Combescure C, Doncesco R, et al
    Microbial translocation is correlated with HIV evolution in HIV-HCV co-infected patients.
    PLoS One. 2017;12:e0183372.
    PubMed     Text format     Abstract available

  22. ROSINSKA M, Parda N, Kolakowska A, Godzik P, et al
    Factors associated with hepatitis C prevalence differ by the stage of liver fibrosis: A cross-sectional study in the general population in Poland, 2012-2016.
    PLoS One. 2017;12:e0185055.
    PubMed     Text format     Abstract available

  23. UITTE DE WILLIGE S, Keane FM, Bowen DG, Malfliet JJMC, et al
    Circulating fibroblast activation protein activity and antigen levels correlate strongly when measured in liver disease and coronary heart disease.
    PLoS One. 2017;12:e0178987.
    PubMed     Text format     Abstract available

  24. KRAUSKOPF J, de Kok TM, Schomaker SJ, Gosink M, et al
    Serum microRNA signatures as "liquid biopsies" for interrogating hepatotoxic mechanisms and liver pathogenesis in human.
    PLoS One. 2017;12:e0177928.
    PubMed     Text format     Abstract available


    PLoS Pathog

  25. WANG L, Kim JY, Liu HM, Lai MMC, et al
    HCV-induced autophagosomes are generated via homotypic fusion of phagophores that mediate HCV RNA replication.
    PLoS Pathog. 2017;13:e1006609.
    PubMed     Text format     Abstract available


    Transplant Proc

  26. FREY A, Ecker EM, Piras-Straub K, Walker A, et al
    Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In Vivo.
    Transplant Proc. 2017;49:1947-1955.
    PubMed     Text format     Abstract available

  27. LIAO HT, Tan P, Huang JW, Yuan KF, et al
    Ledipasvir + Sofosbuvir for Liver Transplant Recipients With Recurrent Hepatitis C: A Systematic Review and Meta-analysis.
    Transplant Proc. 2017;49:1855-1863.
    PubMed     Text format     Abstract available


    Vaccine

  28. BOHM K, Filomena A, Schneiderhan-Marra N, Krause G, et al
    Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology.
    Vaccine. 2017 Sep 14. pii: S0264-410X(17)31189.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: